Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion type Assertion NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_head.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion wasGeneratedBy ECO_0000203 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion wasDerivedFrom befree-2016 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion SIO_000772 20387067 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion evidence source_evidence_literature NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion description "[We questioned whether the dual SRC/ABL kinase inhibitor dasatinib can affect AML cells and whether differences can be observed with normal CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.